EuroMedtech™ 2012 Press Releases

December 5, 2011EuroMedtech™ 2012 looks to set new benchmark for productive partnering Leaders from the international medical technology industry will gather May 31 to June 1, 2012 in Grenoble, France for the fourth annual EuroMedtech™ partnering conference. In 2011, the conference played host to more than 260 delegates representing 205 companies from 27 countries who engaged in 741 one-to-one partnering meetings. In addition, there were eight workshops and panel sessions an...more ►

13 January 2012 Balancing on the innovation high wire The bar is higher than it has ever been for emerging innovators to secure a partnership. Speakers at Tuesday’s plenary luncheon at Biotech Showcase™ 2012 spoke of the realities and substantial challenges of an environment that increasingly incorporates external and internal development programs. more ►

13 January 2012 Lights are flashing green for biotech investment in China While the rest of the world struggles, China is setting new records in venture capital investment, IPO and M&A activity, and partnering deals. more ►

13 January 2012 The exciting state of regenerative medicine Regenerative medicine has the power to transform healthcare, incorporating a wide variety of therapies. When incorporated into clinical practice, regenerative therapies may save USD 250 billion per year in the US alone. more ►

4 January 2012 Seegene: Multiplex assays key to companion diagnostics The quality of medical treatment is dependent on rapid and accurate diagnosing of the disease, as well as safeguarding the life of the patient. Apart from infectious diseases, most diseases do not have that "tell-all" diagnostic marker that provides an adequate picture of the patient and their particular disease. Seegene, Inc., sees a combination of surrogate markers in a single clinically validated assay as the most effective tool in disease identification, treatment and management, while keeping the patient in focus. more ►

4 January 2012 Anton Gueth: Troublesome financing environment to hit early stage companies hard in 2012 The excitement of the industry insiders is unfortunately not matched by those funding and regulating it. The challenges facing the industry are increasing every day. more ►